HMD Foundation donates iLAB unit to Amrita Hospital Faridabad
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Urges Innovators to produce quality products that can be deployed at scale
Construction will begin this year with the new capacity anticipated by 2025
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
India’s efforts are aimed at boosting health at the last mile
Subscribe To Our Newsletter & Stay Updated